Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSPPT2-CC/CT: Amlodipine Folic Acid vs Amlodipine for Stroke Prevention in H-type Hypertension
NCT04974138Phase 4Recruiting
- Sponsor
- Shenzhen Ausa Pharmaceutical
- Start
- Aug 2024
- Primary completion
- Jun 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amlodipine + folic acid in hypertension (HTN), sponsored by Shenzhen Ausa Pharmaceutical. Started Aug 2024; status: recruiting.
02
Drugs
amlodipine + folic acid
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04974138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04974138.